Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
  • Page 1 of 370
  • 1 to 25 of 9248 records
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9254.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8730
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0727
0.0526
0.9642
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0727
0.0526
0.9642
CAMA-1
HR+
Luminal
Ribavirin
15348.211
uM
inf
inf
1.0500 1.0500 0.0000 -0.0410
-5.7835
0.7490
EFM-192B
HER2amp
Luminal
Ribavirin
15387.211
uM
inf
inf
1.0500 1.0500 0.0000 -0.0048
-0.0190
1.2404
HCC1187
TNBC
Basal A
LY294002
PI3K
PI3K
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 -0.0475
-56.7271
0.9642
BT-483
HR+
Luminal
Cetuximab
EGFR
ErbB
9186.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5108
BT-474
HER2amp
Luminal
PS-1145
IKK
NFKB
5905.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0377
-5.6704
0.8461
BT-483
HR+
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9186.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0318
-0.9738
0.6923
CAMA-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7805.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0217
-0.4906
1.1451
EFM-192B
HER2amp
Luminal
Ribavirin
15288.211
uM
inf
inf
1.0500 1.0500 0.0000 -0.0002
-0.0013
0.9250
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5899.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0165
0.0780
0.7056
600MPE
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5899.094
uM
inf
inf
1.0500 1.0500 0.0000 -0.0167
-0.1754
1.0334
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5902.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.0245
BT-20
TNBC
Basal A
Trastuzumab
HER2
ErbB
5903.102
uM
inf
inf
1.0500 1.0500 0.0000 -0.0171
-0.1575
1.2557
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5904.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6537
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10385.095
uM
inf
inf
1.0500 1.0500 0.0000 0.0010
0.0617
0.7986
BT-474
HER2amp
Luminal
Nilotinib
ABL
nRTK
12178.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0369
0.0948
0.6127
AU565
HER2amp
Luminal
Selumetinib
MEK
MAPK
10880.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0108
-0.1312
1.5205
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5904.085
uM
inf
inf
1.0500 1.0500 0.0000 -0.0334
-1.4110
1.2247
BT-474
HER2amp
Luminal
PS-1145
IKK
NFKB
5906.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0021
-0.0022
0.6586
BT-549
TNBC
Basal B
GW-5074
CRAF
MAPK
5909.088
uM
inf
inf
1.0500 1.0500 0.0000 -0.0255
-2.9579
2.9659
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
HCC1419
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
10019.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0250
-0.1954
0.4626
HCC1395
TNBC
Basal B
Nilotinib
ABL
nRTK
12000.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0614
0.0000
0.6084
  • Page 1 of 370
  • 1 to 25 of 9248 records